| Aveanna Healthcare | |
| 4745 North 7th Street, Suite 432, Phoenix, Arizona 85014 | |
| (602) 433-1200 | |
| Not Available |
| Name | Aveanna Healthcare |
|---|---|
| Location | 4745 North 7th Street, Suite 432, Phoenix, Arizona |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology |
| Medicare ID | 37204 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 85017, 85023, 85203, 85340 |
| NPI Number | 1013156470 |
| Organization Name | ANDVENTURE, LLC |
| Doing Business As | AVEANNA HEALTHCARE |
| Address | 4745 N 7th St Ste 432, Phoenix, AZ 85014 |
| Phone Number | 602-433-1200 |
News Archive
Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking Gleevec® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.
Researchers review the various properties and use of nanoparticles in targeting SARS-CoV-2 and how they could be used to develop new therapeutics and diagnostics for SARS-CoV-2.
Each year, thousands of Canadian men with prostate cancer undergo biopsies to help their doctors better understand the progression and nature of their disease. It provides vital, sometimes life-saving information, yet cancer researcher John Lewis knows it can be a difficult test to ask of anyone.
A work led by SISSA and published on Nature Nanotechnology reports for the first time experimentally the phenomenon of ion 'trapping' by graphene carpets and its effect on the communication between neurons.
› Verified 8 days ago
| Quality Rating: | Not Available* |
| * This measure currently does not have data or provider has been certified/recertified for less than 6 months. | |
News Archive
Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking Gleevec® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.
Researchers review the various properties and use of nanoparticles in targeting SARS-CoV-2 and how they could be used to develop new therapeutics and diagnostics for SARS-CoV-2.
Each year, thousands of Canadian men with prostate cancer undergo biopsies to help their doctors better understand the progression and nature of their disease. It provides vital, sometimes life-saving information, yet cancer researcher John Lewis knows it can be a difficult test to ask of anyone.
A work led by SISSA and published on Nature Nanotechnology reports for the first time experimentally the phenomenon of ion 'trapping' by graphene carpets and its effect on the communication between neurons.
› Verified 8 days ago
News Archive
Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking Gleevec® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.
Researchers review the various properties and use of nanoparticles in targeting SARS-CoV-2 and how they could be used to develop new therapeutics and diagnostics for SARS-CoV-2.
Each year, thousands of Canadian men with prostate cancer undergo biopsies to help their doctors better understand the progression and nature of their disease. It provides vital, sometimes life-saving information, yet cancer researcher John Lewis knows it can be a difficult test to ask of anyone.
A work led by SISSA and published on Nature Nanotechnology reports for the first time experimentally the phenomenon of ion 'trapping' by graphene carpets and its effect on the communication between neurons.
› Verified 8 days ago
Hospice Of The Valley Home Health Agency Location: 1510 East Flower Street, Phoenix, Arizona 85014 Ratings: NA Phone: (602) 530-6900 | |
Kindred At Home Location: 16620 North 40th Street, Suite D4, Phoenix, Arizona 85032 Ratings: Phone: (602) 992-0709 | |
Bayada Home Health Care, Inc. Location: 706 East Bell Road, Suite 111, Phoenix, Arizona 85022 Ratings: NA Phone: (602) 870-6364 | |
Foundation For Senior Living Home Health Agency Location: 1201 East Thomas Road, Phoenix, Arizona 85014 Ratings: Phone: (602) 285-1800 | |
Amedisys Home Health Care Location: 5045 North 12th Street, Suite 100, Phoenix, Arizona 85014 Ratings: Phone: (602) 200-0835 | |
Md Home Health Location: 7500 Dreamy Draw Drive, Suite 200, Phoenix, Arizona 85020 Ratings: Phone: (602) 266-9971 |